Section Arrow
Quote
MLAB.NASDAQ
- Mesa Laboratories
Quotes are at least 15-min delayed:2026/01/21 08:29 EST
Pre Market
Last
 --
-- (--)
Bid
55.75
Ask
132.59
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 82.87
-5.82 (-6.56%)
Day High 
87.98 
Prev. Close
88.69 
1-M High
89.95 
Volume 
126.76K 
Bid
55.75
Ask
132.59
Day Low
82.32 
Open
86.01 
1-M Low
76.974 
Market Cap 
489.77M 
Currency 美元 
P/E 510.41 
%Yield 0.77 
10-SMA 86.02 
20-SMA 83.08 
50-SMA 79.33 
52-W High 155.12 
52-W Low 55.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.31/6.85
Enterprise Value
566.67M
Balance Sheet
Book Value Per Share
32.32
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
6.60M
Operating Revenue Per Share
38.70
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ARBEArbe Robotics Ltd1.18+0.04+3.51%-- 
Pre Market 1.18 0 0.00%
COHRCoherent Corp193.46+2.42+1.27%268.87PE
Pre Market 198.5 +5.04 +2.61%
MVISMicroVision0.8583-0.0311-3.50%-- 
Pre Market 0.89 +0.0317 +3.69%
TRMBTrimble69.59-4.3-5.82%50.99PE
Pre Market 69.73 +0.14 +0.20%
FTVFortive Corp52.7-2.26-4.11%21.64PE
Pre Market 52.7 0 0.00%
Industry overview quotes are at least 15 minutes delayed
Business Description
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicatorsused to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.